Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma

Overview of attention for article published in Journal of Neuro-Oncology, February 2019

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 553 followers.

Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma. - PubMed - NCBI https://t.co/mdLPqSYc3q

#newupdatesneuroonc #braintumours #neuroonc Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma. - https://t.co/kprPAaLI8q

#newupdatesneuroonc #braintumours #neuroonc Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma - https://t.co/xGkYV3lQCJ

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.